CB MED
The computed 12-month bankruptcy probability of CB MED is 0.1% (very low). The company has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 23 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 29-08-2025 | 2025-00445345 |
| 31-12-2023 | volledig | 26-06-2024 | 2024-00171353 |
| 31-12-2022 | volledig | 31-08-2023 | 2023-00414827 |
| 31-12-2021 | volledig | 29-06-2022 | 2022-20114510 |
| 31-12-2020 | volledig | 11-08-2021 | 2021-47900230 |
| 31-12-2019 | volledig | 08-10-2020 | 2020-59900200 |
| 31-12-2018 | volledig | 30-08-2019 | 2019-59300379 |
| 31-12-2017 | volledig | 28-08-2018 | 2018-53700202 |
| 31-12-2016 | volledig | 25-08-2017 | 2017-49500270 |
| 31-12-2015 | volledig | 26-08-2016 | 2016-48800455 |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 18-12-2002 |
| Status | Active |
| Postal code | 4650 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63039A0334/00R000 | Wallonia | 2,928 m² | 1 · 254 m² | 7.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-01-2024 Capital increase of €8,060 to €0
- €8.060 → €0
Technical details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": 0.0,
"delta_eur": 8060.0,
"before_eur": 8060.0,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": 12400.0,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Fr\u00E9d\u00E9ric LOMBARDO",
"firm_city": null,
"firm_name": null,
"office_city": "Aubel",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-01-11",
"filing_date": "2024-01-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-12-26",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.045.881",
"name_full": "CB MED",
"legal_form": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"copie certifi\u00E9e conforme du proc\u00E8s-verbal",
"statuts coordonn\u00E9s"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 186,
"class_name": "actions",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | CB MED |